Oral Delivery of Lipid Nanosystem: Pharmacokinetics and Pharmacodynamic Advances

Nanolipid-based drug delivery systems are a new milestone to be achieved in the field of pharmaceutical science as it integrates the advantages of lipid carriers with nanoscale features. The oral administration of such systems promises better drug bioavailability, targeted delivery, and novel sustained release profiles which help in overcoming the physiological hurdles posed by the gastrointestinal tract. Formulation stability and therapeutic efficacy have recently seen improvement alongside promising preclinical results. Regulatory frameworks are also starting to appreciate the potential these novel carriers offer. There seems to be a paradigm shift as evolution in the field would foster intelligent personalized therapies for increased patient care. Enhanced therapy will integrate smart delivery systems alongside scalable nanolipid system manufacturing.